Insurance Red Tape Keeps Blistering Disease Patients From Lifesaving Biologics
A new survey of United States patients with autoimmune blistering diseases documents how insurance requirements such as prior authorization and ...
A new survey of United States patients with autoimmune blistering diseases documents how insurance requirements such as prior authorization and ...
A longitudinal fluoride PET/CT study shows that spinal lesions of axial spondyloarthritis shrink and cool down during biologic treatment while ...
A new narrative review maps how methotrexate, biologics, and JAK inhibitors are transforming the management of pediatric morphea, a rare ...
A Mount Sinai retrospective analysis suggests GLP-1 receptor agonists may reduce cardiovascular risk, inflammation, and disease severity in hidradenitis suppurativa.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.